The introduction of NTCP-overexpressing hepatoma cell lines, such as HuH7-NTCP and HepG2-NTCP, following the 2012 discovery of NTCP as an HBV infection receptor, has significantly advanced studies on cell entry inhibitors [34]. The gene discussed is SLC10A1; the disease is hepatocellular carcinoma.